188 related articles for article (PubMed ID: 36869396)
21. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.
Lee K; Song JS; Kim JE; Kim W; Song SY; Lee MH; Chung HW; Cho KJ; Lee JS; Ahn JH
Eur J Surg Oncol; 2020 Jul; 46(7):1287-1293. PubMed ID: 32127249
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
[TBL] [Abstract][Full Text] [Related]
23. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.
Folkert MR; Singer S; Brennan MF; Kuk D; Qin LX; Kobayashi WK; Crago AM; Alektiar KM
J Clin Oncol; 2014 Oct; 32(29):3236-41. PubMed ID: 25185087
[TBL] [Abstract][Full Text] [Related]
24. Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center.
Montero A; Chen-Zhao X; Ciérvide R; Álvarez B; Prado A; López M; Sánchez E; Hernando O; de la Casa MA; García-Aranda M; Valero J; Alonso R; Fernández-Letón P; Rubio C
Clin Transl Oncol; 2024 Jan; 26(1):204-213. PubMed ID: 37277526
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.
Nishida Y; Tsukushi S; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2010 Nov; 468(11):3041-6. PubMed ID: 20499293
[TBL] [Abstract][Full Text] [Related]
26. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
[TBL] [Abstract][Full Text] [Related]
27. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
[TBL] [Abstract][Full Text] [Related]
28. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.
Canter RJ; Borys D; Olusanya A; Li CS; Lee LY; Boutin RD; Christensen SD; Tamurian RM; Monjazeb AM
Ann Surg Oncol; 2014 May; 21(5):1616-23. PubMed ID: 24554062
[TBL] [Abstract][Full Text] [Related]
29. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative versus postoperative radiotherapy in soft tissue sarcomas: State of the art and perspectives].
Levy A; Honoré C; Dumont S; Bourdais R; Cavalcanti A; Faron M; Ngo C; Haddag-Miliani L; Le Cesne A; Mir O; Le Péchoux C
Bull Cancer; 2021 Sep; 108(9):868-876. PubMed ID: 34246458
[TBL] [Abstract][Full Text] [Related]
31. Effect of negative pressure wound therapy after surgical removal of deep-seated high-malignant soft tissue sarcomas of the extremities and trunk wall-study protocol for a randomized controlled trial.
Yilmaz M; Thorn A; Sørensen MS; Jensen CL; Petersen MM
Trials; 2022 Jun; 23(1):507. PubMed ID: 35717239
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma.
Allignet B; Waissi W; Geets X; Dufresne A; Brahmi M; Ray-Coquard I; Blay JY; Bouhamama A; Meeus P; Vaz G; Gouin F; Moncharmont C; Sunyach MP
Radiother Oncol; 2022 Aug; 173():55-61. PubMed ID: 35640770
[TBL] [Abstract][Full Text] [Related]
33. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
[TBL] [Abstract][Full Text] [Related]
35. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
36. A systematic overview of radiation therapy effects in soft tissue sarcomas.
Strander H; Turesson I; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):516-31. PubMed ID: 14596510
[TBL] [Abstract][Full Text] [Related]
37. Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?
Levy A; Bonvalot S; Bellefqih S; Vilcot L; Rimareix F; Terrier P; Belemsagha D; Cascales A; Domont J; Mir O; Honoré C; Le Cesne A; Le Péchoux C
Eur J Surg Oncol; 2014 Dec; 40(12):1648-54. PubMed ID: 25130960
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
[TBL] [Abstract][Full Text] [Related]
40. [Soft tissue sarcoma: prognostic factors and multimodal treatment].
Hoos A; Lewis JJ; Brennan MF
Chirurg; 2000 Jul; 71(7):787-94. PubMed ID: 10986600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
